跳至主要内容
临床试验/NCT06151379
NCT06151379已完成不适用

The Relation Between the Initial Value of the Skeletal Mass Index and Pathological Response

Acıbadem Atunizade Hospital1 个研究点 分布在 1 个国家目标入组 69 人开始时间: 2023年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
69
试验地点
1
主要终点
Sarcopenic index

研究概览

简要总结

The investigators aimed to accurately measure muscle mass and predict pCR to NAC and its effect on clinical outcomes.

详细描述

In patients with operable breast cancer (BC) receiving neoadjuvant chemotherapy (NAC), the pathological response rate was found to be related to body composition. The success of complete pathologic response (pCR) is a known prognostic factor in BC patients treated with NAC. The investigators aimed to accurately measure muscle mass and predict pCR to NAC and its effect on clinical outcomes.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
29 Years 至 72 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Early and locally advanced operated breast cancer patients receiving neoadjuvant chemotherapy.

排除标准

  • Patients who did not receive neoadjuvant chemotherapy, had metastatic breast cancer and whose radiological images were not available.

结局指标

主要结局

Sarcopenic index

时间窗: Through study completion, an average of 1 year.

skeletal muscle area (cm2)/height (m2) et L3 level

次要结局

  • Body mass index(Through study completion, an average of 1 year.)

研究者

发起方
Acıbadem Atunizade Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ebru Yilmaz

Principal Investigator

Acıbadem Atunizade Hospital

研究点 (1)

Loading locations...

相似试验